Fair 21°
Tag:

Pharmaceuticals

Police & Fire
CT Psychiatrist to Pay $455K For Over-Prescribing 'Holy Trinity' Of Dangerous Drugs: Feds CT Psychiatrist to Pay $455K For Over-Prescribing 'Holy Trinity' Of Dangerous Drugs: Feds
CT Psychiatrist to Pay $455K For Over-Prescribing 'Holy Trinity' Of Dangerous Drugs: Feds A Connecticut psychiatrist has agreed to pay $455,439 to resolve allegations that he issued large amounts of medically unnecessary prescriptions and submitted false claims to Medicare and Medicaid, federal and state officials announced. Dr. Naimetulla Ahmed Syed, formerly practicing in Danbury and New Haven, was accused of prescribing dangerously high amounts of controlled substances without a legitimate medical purpose between 2016 and 2021, the US Attorney for Connecticut said. Investigators alleged that Syed’s prescriptions often included benzodiazepines and other high-risk drug combinat…

SHARE

by Josh Lanier
News
COVID-19: Cats, Dogs, Caviar, Here Are Odd Shortages Caused By The Pandemic COVID-19: Cats, Dogs, Caviar, Here Are Odd Shortages Caused By The Pandemic
Covid-19: Cats, Dogs, Caviar, Here Are Odd Shortages Caused By The Pandemic The COVID-19 pandemic and subsequent economic turmoil are leading to supply shortages in places you might not have considered. Among purchasables in short-supply are cats and dogs up for adoption to baking yeast, jigsaw puzzles, and truffles among other things. When COVID-19 closed much of the economy in March 2020, items that include toilet paper, paper towels, cleaning supplies, coins, meat, and flour were among the first pandemic-related shortages Americans experienced. Most of those shortages have been addressed by manufacturers and supply chains. But as the U.S. comes up on one year…

SHARE

by Kristin Palpini
Business
Stamford-Based Purdue Pharma Admits To Crimes, Facing Billions In Fines For Opioid Crisis Role Stamford-Based Purdue Pharma Admits To Crimes, Facing Billions In Fines For Opioid Crisis Role
Stamford-Based Purdue Pharma Admits To Crimes, Facing Billions In Fines For Opioid Crisis Role Purdue Pharma, the maker of OxyContin, has agreed to pay billions of dollars in fines and will plead guilty to federal criminal charges for its role in the nation’s opioid crisis. The Fairfield County-based Connecticut company agreed to plead guilty in federal court in New Jersey to a three-count indictment that includes one count of dual-object conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act, and two counts of conspiracy to violate the Federal Anti-Kickback Statute. As part of the agreement, Purdue Pharma, whose headquarters is in Stamford, will…

SHARE

by Zak Failla
Lifestyle
Recall Alert: Pharma Company Pulls Infant Ibuprofen From CVS, Walmart, Family Dollar Recall Alert: Pharma Company Pulls Infant Ibuprofen From CVS, Walmart, Family Dollar
Recall Alert: Pharma Company Pulls Infant Ibuprofen From CVS, Walmart, Family Dollar Tris Pharma, Inc. has voluntarily recalled a popular infant’s Ibuprofen product that is being sold at Walmart, CVS and Family Dollar. The recalled lots from the three stores include Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled products have been found to potentially have higher concentrations of ibuprofen. According to the company, there is a “remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury.” Adv…

SHARE

by Zak Failla
Lifestyle
Nearly 200K Birth Control Pills Recalled Nearly 200K Birth Control Pills Recalled
Nearly 200K Birth Control Pills Recalled Nearly 200,000 sample packs of birth Allergan birth control pills have been recalled after placebos were placed out of order, which could lead to an unexpected pregnancy. Officials announced this week that the company is recalling almost 170,000 pills after active capsules and placebos were placed out of order, causing a potential risk to those using the sample packs. The packs are marked as Taytullla Softgel Capsules with the lot number 5620706 and have a May 2019 expiration date. The company issued its national recall after a doctor reported a sample pack containing the first four days o…

SHARE

by Zak Failla